Statera Biopharma, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Statera Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2022.
  • Statera Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 50.7M shares, a 58.1% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 50.7M +18.6M +58.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 49.6M +34.2M +221% Jun 30, 2022 10-Q 2022-10-28
Q1 2022 50M +34.5M +223% Mar 31, 2022 10-Q 2022-10-21
Q4 2021 35.5M +22.1M +165% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 32.1M +19.1M +147% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 15.5M +2.54M +19.7% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 15.5M +4.07M +35.7% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 13.4M +2.08M +18.4% Dec 31, 2020 10-Q 2021-08-16
Q3 2020 13M +1.72M +15.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 12.9M +1.63M +14.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 11.4M +105K +0.93% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 11.3M 0 0% Dec 31, 2019 10-K 2021-03-22
Q3 2019 11.3M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 11.3M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 11.3M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 11.3M +18.4K +0.16% Dec 31, 2018 10-K 2020-04-15
Q3 2018 11.3M +18.4K +0.16% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 11.3M +18.4K +0.16% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 11.3M +311K +2.83% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 11.3M +293K +2.66% Dec 31, 2017 10-K 2019-03-07
Q3 2017 11.3M +293K +2.66% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 11.3M +293K +2.66% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 11M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 11M 0 0% Dec 31, 2016 10-K 2018-03-06
Q3 2016 11M +256K +2.39% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 11M +6.72M +157% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 11M +7.55M +220% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 11M +8.13M +284% Dec 31, 2015 10-K 2017-02-22
Q3 2015 10.7M -46.4M -81.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 4.27M -52.8M -92.5% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 3.44M -47.5M -93.3% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 2.86M +598K +26.5% Dec 31, 2014 10-K 2016-02-23
Q3 2014 57.1M +12M +26.5% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 57.1M +12.1M +27% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 50.9M +6.03M +13.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 2.26M -42.5M -94.9% Dec 31, 2013 10-K 2015-02-27
Q3 2013 45.2M +9.22M +25.7% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 45M +9.13M +25.5% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 44.9M +9.22M +25.8% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 44.7M +9.12M +25.6% Dec 31, 2012 10-K 2014-03-17
Q3 2012 35.9M +457K +1.29% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 35.8M +463K +1.31% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 35.7M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 35.6M +6.65M +23% Dec 31, 2011 10-K 2013-03-18
Q3 2011 35.5M Sep 30, 2011 10-Q/A 2011-11-14
Q2 2011 35.4M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 29M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.